Ryvu Therapeutics S.A. (WSE: RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 23.01M PLN in the quarter ending June 30, 2024, with 53.08% growth. This brings the company's revenue in the last twelve months to 82.39M, down -6.06% year-over-year. In the year 2023, Ryvu Therapeutics had annual revenue of 67.30M, down -1.67%.

• Revenue (ttm): 82.39M
• Revenue Growth: -6.06%
• P/S Ratio: 14.65
• Revenue / Employee: 305.14K
• Employees: 270
• Market Cap: 1.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%
Dec 31, 2020	36.95M	3.23M	9.58%
Dec 31, 2019	33.72M	-17.96M	-34.75%